Hints and tips:
Showing results for Merrell Dow Pharmaceuticals, Inc.
...It is also used for applications in the marine, medical, military, pharmaceutical, semiconductor and textile industries....
...S&P Dow Jones Indices, which manages the benchmark, snubbed the California electric vehicle maker in the first round of additions since June, which were announced late on Friday....
...The old conglomerate merged in 2017 with Dow Chemical, but was split this year into three businesses....
...According to Dow Jones VentureSource, Germany is expected to have recorded almost $7bn of venture capital investments in 2019, more than double the figure two years earlier....
...Sales soared 88 per cent to $7.2bn last year, helping the company’s stock record the best performance in the Dow in 2018....
...Merck was the top performer in the 30-member Dow Jones Industrial Average last year, with a 35.8 per cent gain, but it is now the second-worst performer in the gauge so far in 2019, down 2.6 per cent....
...Merck was the best performer in the Dow Jones Industrial Average last year, up 35.8 per cent, helped by investors’ excitement at the sales of Keytruda....
...Johnson & Johnson posted upbeat quarterly results on the back of strength in its pharmaceuticals unit, sending its shares modestly higher in early trade....
...The Dow Jones Industrial Average ended the day up 0.19 per cent to 22,412.6, lifted by gains for burger chain McDonald’s, pharmaceutical giant Pfizer and aerospace manufacturer Boeing, while Apple weighed...
...The Dow Jones Industrial Average also fell 0.36 per cent to 23,348.7, while the Nasdaq Composite ended nearly flat at 6,698.9....
...The S&P 500 gained 0.1 per cent to 2,560.40 and the Dow Jones Industrial Average added 0.3 per cent to 23,400.86....
...Kenneth Frazier, the African-American chief executive of pharmaceuticals group Merck, set off a chain reaction on Monday when he resigned from a manufacturing panel convened by the president....
...Elsewhere, the Dow Jones Industrial Average dipped 0.3 per to 21,410 and the tech heavy Nasdaq Composite rose 0.7 per cent top 6,233....
...Hemmed in between gargantuan suppliers of natural resources — often oil and gas groups — on one side, and large customers in sectors such as automotive, consumer goods and pharmaceuticals on the other, chemicals...
...The Nasdaq Composite edged up by 0.3 per cent to 6,169.9, while the Dow Jones Industrial Average was little changed at 20,979.8. Additional reporting by David Crow...
...The Dow Jones Industrial Average fell 0.2 per cent to 20,054 and the Nasdaq Composite recovered earlier lost ground to end up 0.2 per cent at 5,682....
...Given such a difficult backdrop, the FTSE 350 pharmaceuticals and biotechnology index ended the year down more by more than 10 per cent even as both the Dow Jones Industrial Average and the FTSE 100 finished...
...Martin Arnold in London The Snap IPO Technology investors’ eyes will be firmly on whether Snap Inc can snap, crackle and pop on its stock market debut, expected as early as March 2017....
...Regeneron rose 3.6 per cent to $418.65, Vertex Pharmaceuticals gained 3 per cent to $100.96 and Alexion Pharmaceuticals climbing 3.3 per cent to $136.53....
...The Dow Jones Industrial Average shed 63 points, or 0.3 per cent, to 19,890. In Brazil, the Bovespa stock index rose 2.4 per cent....
...The news reported by the Wall Street Journal comes a day after Biogen along with Ionis Pharmaceuticals unveiled upbeat results from a trial for a drug that treats a potentially fatal muscular disorder in...
...The Dow Jones Industrial Average gained another 0.2 per cent to 19,796, buoyed by energy stocks surging on the back of rising oil prices....
...At the close, the S&P 500 was down 0.6 per cent to 2,164.7, the Dow Jones Industrial Average had declined 0.7 per cent to 18,261.5. The Nasdaq Composite edged 0.6 per cent lower to 5,305.8....
...In Canada, attention was focused on Concordia International, a pharmaceuticals company....
International Edition